Task B22: Comprehensive In Vitro Antiviral Screening Against BSL-4 Pathogens

NIH RePORTER · NIH · N01 · $540,000 · view on reporter.nih.gov ↗

Abstract

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

Key facts

NIH application ID: 11080805
Project number: 75N93019D00021-0-759302400001-1
Recipient: UTAH STATE UNIVERSITY
Principal Investigator: BRETT HURST
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $540,000
Award type: —
Project period: 2024-03-13 → 2025-03-12